Intervention Protocol

Retigabine add-on for refractory partial-onset seizures

  1. Saif Huda1,*,
  2. Arif Shukralla2,
  3. Anthony G Marson2

Editorial Group: Cochrane Epilepsy Group

Published Online: 5 OCT 2011

Assessed as up-to-date: 30 AUG 2011

DOI: 10.1002/14651858.CD009368


How to Cite

Huda S, Shukralla A, Marson AG. Retigabine add-on for refractory partial-onset seizures (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD009368. DOI: 10.1002/14651858.CD009368.

Author Information

  1. 1

    The Walton NHS Foundation Trust, Department of Neurology, Liverpool, Merseyside, UK

  2. 2

    Institute of Translational Medicine, University of Liverpool, Department of Molecular and Clinical Pharmacology, Liverpool, UK

*Saif Huda, Department of Neurology, The Walton NHS Foundation Trust, Lower Lane, Fazakerley, Liverpool, Merseyside, L9 7LJ, UK. Saif.Huda@thewaltoncentre.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 5 OCT 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the efficacy and tolerability of retigabine as an add-on therapy for people with refractory partial onset seizures.